BROADCASTS.com

b'

Dr. Angeli M\\xf6ller, Ph.D, is Head of the Data and Integrations Generating Insights Group (DIGI) at Roche ( https://www.roche.com/ ), which is a fascinating group focused on bringing together data & technology from Roche diagnostics and pharma divisions to enable innovation for patients. Previously, Dr. M\\xf6ller served as Head of Pharma Informatics International at Roche focused specifically on driving the employment of AI technologies to help get the right treatment to the right patient at the right time. Prior to joining Roche, Dr. M\\xf6ller led the artificial intelligence workstream and was responsible for the research digital investment strategy at Bayer Pharmaceuticals. Before Bayer, she worked as a data scientist for translational medicine at Thomson Reuters and researcher at Cancer Research UK and the Max Delbr\\xfcck Center for Molecular Medicine. As a proponent of pre-competitive collaboration, Dr. M\\xf6ller co-founded the Alliance for Artificial Intelligence in Healthcare (AAIH), where she is Vice Chair and is also a member of the scientific advisory board of Multiomic Health. She also serves as a Member of The Science and Technology Facilities Council (STFC) of UK Research and Innovation (UKRI), which supports research in astronomy, physics and space science, and operates world-class research facilities for the UK. Dr. M\\xf6ller has her Bachelor of Science (BSc) in Molecular Biology from University of Aberdeen, her Ph.D. in Molecular Biology with an oncology focus, from The University of Edinburgh, and did post-doc work in the neuroproteomics of neurodegeneration at the Max Delbr\\xfcck Center for Molecular Medicine.\\xa0